Velg regionen som passer best for din plassering eller dine preferanser.
Denne innstillingen kontrollerer språket for brukergrensesnittet, inkludert knapper, menyer og all tekst på nettstedet. Velg ditt foretrukne språk for best brukeropplevelse.
Velg språkene for stillingsannonser du vil se. Denne innstillingen bestemmer hvilke stillingsannonser som vises for deg.
St. Anna Children’s Cancer Research Institute (CCRI) strives to improve treatment for children and adolescents with cancer by bringing together translational and clinical research with open-minded exploration of basic disease mechanisms. Every year, 250-300 children and adolescents in Austria alone are diagnosed with cancer. Thanks to research, more than 80 % of these children will now survive. Integrally connected with St. Anna Children’s Hospital, experimental and theoretical scientists at CCRI work side-by-side with oncologists to tackle eminent issues in pediatric cancer research and therapy.
The CCRI trains a generation of passionate and courageous researchers thriving on this interdisciplinary exchange and it hosts state-of-the-art experimental facilities to power this mission. CCRI tears down conventional boundaries by constant exchange and collaboration with outside institutions in order to go the extra mile for the benefit of the patient. Bringing research from bench to bedside, CCRI headquarters multiple clinical trials and is tightly integrated in international networks to maximize innovation and impact.
Based on decades of biomedical research, we now have data and bioinformatics tools at our disposal to investigate more precisely than ever before the molecular characteristics of cancer development, disease progression and healing processes. Deciphering the human genome, epigenome, proteins, etc., provides crucial information to combat rare diseases such as childhood cancer. This corresponds to the definition of precision oncology, according to which precise treatment is based on a deep molecular understanding of the disease.
There is one basic motive behind the research performed at CCRI: The search for high-precision and fast acting new weapons against cancer in children. Hence, the intensive research activities are all about exposing the strategies and schemes of cancer, this frightening master of survival, as well as developing breakthrough therapies for better treatment or, in the best case, the healing of children affected by cancer. In pursuit of these goals, we employ the most cutting-edge biomedical methods to confront pediatric cancer – be it in terms of deciphering its causes or of providing well-devised, innovative treatment concepts.In so doing, CCRI is one of the top addresses for the treatment of pediatric cancer according to the maxim “from bench to bedside” i.e., the commitment to inseparably tie clinical practice to research, in order to expand the knowledge about this deadly disease.
Prof. Dr. Kaan Boztug (MD), Scientific director CCRI